Dr. Andrew Mesecar is a prominent researcher specializing in biochemistry, structural biology, and cancer drug discovery. His key research features and contributions include:
), helping guide the development of treatments like . mesecar
He is the Robert Wallace Miller Director of the Purdue Institute for Cancer Research , where he leads efforts in developing novel cancer therapies, diagnostics, and targeting cancer at the cellular level. He is the Robert Wallace Miller Director of
His work includes developing non-covalent, selective inhibitors designed to work against multiple emerging coronavirus strains, including MERS-CoV. Mesecar's team played a crucial role in identifying
Dr. Mesecar's team played a crucial role in identifying the antiviral X77 , which was effective against the SARS-CoV-2 main protease ( Mprocap M raised to the p r o power
He is involved in translational research to turn basic molecular findings into commercial drugs for cancer and Alzheimer's disease.
He specializes in determining high-resolution 3D structures of enzymes (such as 3CLpro and PLpro) in coronaviruses and cancer to design selective drugs.